Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
December 4, 2012
Molecular pathogenesis of neuromyelitis optica
Wajih Bukhari, Michael H Barnett, Kerri Prain, et al.
Journal of Neurology
|
July 2, 2021
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand
Wajih Bukhari, Elham Khalilidehkordi, Deborah F Mason, et al.
Frontiers in Neurology
|
October 23, 2019
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
Kerri Prain, Mark Woodhall, Angela Vincent, et al.
Multiple Sclerosis and Related Disorders
|
February 26, 2022
Response to treatment in NMOSD: the Australasian experience
Laura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Journal of Neurology
|
February 2, 2020
The clinical profile of NMOSD in Australia and New Zealand
Wajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 28, 2017
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Frontiers in Neurology
|
July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Frontiers in Neurology
|
September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
Laura Clarke, Simon Arnett, Wajih Bukhari, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
December 4, 2012
Molecular pathogenesis of neuromyelitis optica
Wajih Bukhari, Michael H Barnett, Kerri Prain, et al.
Journal of Neurology
|
July 2, 2021
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand
Wajih Bukhari, Elham Khalilidehkordi, Deborah F Mason, et al.
Frontiers in Neurology
|
October 23, 2019
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
Kerri Prain, Mark Woodhall, Angela Vincent, et al.
Multiple Sclerosis and Related Disorders
|
February 26, 2022
Response to treatment in NMOSD: the Australasian experience
Laura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Journal of Neurology
|
February 2, 2020
The clinical profile of NMOSD in Australia and New Zealand
Wajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 28, 2017
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Frontiers in Neurology
|
July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Frontiers in Neurology
|
September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
Laura Clarke, Simon Arnett, Wajih Bukhari, et al.
Page
of 1